Grant of Interim Extension of the Term of U.S. Patent No. 4,650,787; Sanvar®, 20256-20257 [E8-8058]
Download as PDF
<![CDATA[
20256
Federal Register / Vol. 73, No. 73 / Tuesday, April 15, 2008 / Notices
Constructed Export Price Sales:
• Generally, a U.S. sale is classified as a
constructed export price sale when the first
sale to an unaffiliated customer occurs after
importation. However, if the first sale to the
unaffiliated customer is made by a person in
the United States affiliated with the foreign
exporter, constructed export price applies
even if the sale occurs prior to importation.
• Please include any sales exported by
your company directly to the United States;
• Please include any sales exported by
your company to a third-country market
economy reseller where you had knowledge
that the merchandise was destined to be
resold to the United States.
• If you are a producer of subject
merchandise, please include any sales
manufactured by your company that were
subsequently exported by an affiliated
exporter to the United States.
• Please do not include any sales of subject
merchandise manufactured in Hong Kong in
your figures.
Further Manufactured:
• Sales of further manufactured or
assembled (including re-packaged)
merchandise is merchandise that undergoes
further manufacture or assembly in the
United States before being sold to the first
unaffiliated customer.
• Further manufacture or assembly costs
include amounts incurred for direct
materials, labor and overhead, plus amounts
for general and administrative expense,
interest expense, and additional packing
expense incurred in the country of further
manufacture, as well as all costs involved in
moving the product from the U.S. port of
entry to the further manufacturer.
[FR Doc. E8–8006 Filed 4–14–08; 8:45 am]
BILLING CODE 3510–DS–P
DEPARTMENT OF COMMERCE
National Oceanic and Atmospheric
Administration
Proposed Information Collection;
Comment Request; NOAA Customer
Surveys
14th and Constitution Avenue, NW.,
Washington, DC 20230 (or via the
Internet at dHynek@doc.gov).
FOR FURTHER INFORMATION CONTACT:
Requests for additional information or
copies of the information collection
instrument and instructions should be
directed to Sarah Brabson, 301–713–
3333 ext. 204 or
sarah.brabson@noaa.gov.
SUPPLEMENTARY INFORMATION:
I. Abstract
This is a request for renewal of a
generic clearance for voluntary
customer surveys to be conducted by
NOAA program offices, and is
submitted following the guidelines
contained in the OMB Resource Manual
for Customer Surveys. In accordance
with Executive Order 12862, the
National Performance Review, and good
management practices, NOAA offices
seek approval to continue to gather
customer feedback on services and/or
products, which can be used in
planning for service/product
modification and prioritization.
Under this generic clearance,
individual offices would use approved
questionnaires and develop new
questionnaires, as needed, by selecting
subsets of the approved set of collection
questions and tailoring those specific
questions to be meaningful for their
particular programs. These proposed
questionnaires would then be submitted
to OMB using a fast-track request for
approval process. The generic clearance
will not be used to survey any bodies
NOAA regulates unless precautions are
taken to ensure that the respondents
believe that they are not under any risk
for not responding or for the contents of
their responses; e.g., in no survey to
such a population will the names and
addresses of respondents be required.
Currently there are no such surveys
being submitted for approval.
National Oceanic and
Atmospheric Administration (NOAA).
ACTION: Notice.
jlentini on PROD1PC65 with NOTICES
AGENCY:
II. Method of Collection
Information is collected via e-mail or
interactive Web sites.
SUMMARY: The Department of
Commerce, as part of its continuing
effort to reduce paperwork and
respondent burden, invites the general
public and other Federal agencies to
take this opportunity to comment on
proposed and/or continuing information
collections, as required by the
Paperwork Reduction Act of 1995.
DATES: Written comments must be
submitted on or before June 16, 2008.
ADDRESSES: Direct all written comments
to Diana Hynek, Departmental
Paperwork Clearance Officer,
Department of Commerce, Room 6625,
III. Data
OMB Number: 0648–0342.
Form Number: None.
Type of Review: Regular submission.
Affected Public: Individuals or
households; not-for-profit institutions;
business or other for-profit
organizations; and state, local or tribal
governments.
Estimated Number of Respondents:
20,800.
Estimated Time per Response: 5
minutes.
Estimated Total Annual Burden
Hours: 1,800.
VerDate Aug<31>2005
17:31 Apr 14, 2008
Jkt 214001
PO 00000
Frm 00015
Fmt 4703
Sfmt 4703
Estimated Total Annual Cost to
Public: $0.
IV. Request for Comments
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden
(including hours and cost) of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology.
Comments submitted in response to
this notice will be summarized and/or
included in the request for OMB
approval of this information collection;
they also will become a matter of public
record.
Dated: April 10, 2008.
Gwellnar Banks,
Management Analyst, Office of the Chief
Information Officer.
[FR Doc. E8–8009 Filed 4–14–08; 8:45 am]
BILLING CODE 3510–22–P
DEPARTMENT OF COMMERCE
Patent and Trademark Office
[Docket No. PTO–P–2008–0015]
Grant of Interim Extension of the Term
of U.S. Patent No. 4,650,787; Sanvar
United States Patent and
Trademark Office, Department of
Commerce.
ACTION: Notice of Interim Patent Term
Extension.
AGENCY:
SUMMARY: The United States Patent and
Trademark Office has issued an order
granting interim extension under 35
U.S.C. 156(d)(5) for a fourth one-year
interim extension of the term of U.S.
Patent No. 4,650,787.
FOR FURTHER INFORMATION CONTACT:
Mary C. Till by telephone at (571) 272–
7755; by mail marked to her attention
and addressed to the Commissioner for
Patents, Mail Stop Hatch-Waxman PTE,
P.O. Box 1450, Alexandria, VA 22313–
1450; by fax marked to her attention at
(571) 273–7755, or by e-mail to
Mary.Till@uspto.gov.
Section
156 of Title 35, United States Code,
generally provides that the term of a
patent may be extended for a period of
SUPPLEMENTARY INFORMATION:
E:\FR\FM\15APN1.SGM
15APN1
Federal Register / Vol. 73, No. 73 / Tuesday, April 15, 2008 / Notices
up to five years if the patent claims a
product, or a method of making or using
a product, that has been subject to
certain defined regulatory review, and
that the patent may be extended for
interim periods of up to a year if the
regulatory review is anticipated to
extend beyond the expiration date of the
patent.
On March 24, 2008, Debiovision Inc.,
the exclusive agent of Debiopharm S.A.
and Debio Recherche Pharmaceutique
S.A., who is the exclusive licensee of
the Administrators of the Tulane
Educational Fund of New Orleans,
Louisiana, the patent owner, timely
filed an application under 35 U.S.C.
156(d)(5) for a fourth interim extension
of the term of U.S. Patent No. 4,650,787.
The patent claims the human drug
product Sanvar (vapreotide acetate).
The application indicates that a New
Drug Application for the human drug
product Sanvar (vapreotide acetate)
has been filed and is currently
undergoing regulatory review before the
Food and Drug Administration for
permission to market or use the product
commercially.
Review of the application indicates
that except for permission to market or
use the product commercially, the
subject patent would be eligible for an
extension of the patent term under 35
U.S.C. 156, and that the patent should
be extended for an additional one year
as required by 35 U.S.C. 156(d)(5)(B).
Because it is apparent that the
regulatory review period will continue
beyond the extended expiration date of
the patent (April 25, 2008), a fourth
interim extension of the patent term
under 35 U.S.C. 156(d)(5) is appropriate.
A fourth interim extension under 35
U.S.C. 156(d)(5) of the term of U.S.
Patent No. 4,650,787 is granted for a
period of one year from the extended
expiration date of the patent, i.e., until
April 25, 2009.
Dated: April 9, 2008.
Jon W. Dudas,
Under Secretary of Commerce for Intellectual
Property and Director of the United States
Patent and Trademark Office.
[FR Doc. E8–8058 Filed 4–14–08; 8:45 am]
jlentini on PROD1PC65 with NOTICES
BILLING CODE 3510–16–P
VerDate Aug<31>2005
17:31 Apr 14, 2008
Jkt 214001
DEPARTMENT OF COMMERCE
United States Patent and Trademark
Office
Submissions Regarding
Correspondence and Regarding
Attorney Representation (Trademarks)
ACTION:
Proposed collection; comment
request.
SUMMARY: The United States Patent and
Trademark Office (USPTO), as part of its
continuing effort to reduce paperwork
and respondent burden, invites the
general public and other Federal
agencies to take this opportunity to
comment on the extension of a
continuing information collection, as
required by the Paperwork Reduction
Act of 1995, Public Law 104–13 (44
U.S.C. 3506(c)(2)(A)).
DATES: Written comments must be
submitted on or before June 16, 2008.
ADDRESSES: You may submit comments
by any of the following methods:
E-mail: Susan.Fawcett@uspto.gov.
Include ‘‘0651–0056 comment’’ in the
subject line of the message.
Fax: 571–273–0112, marked to the
attention of Susan K. Fawcett.
Mail: Susan K. Fawcett, Records
Officer, Office of the Chief Information
Officer, Customer Information Services
Group, Public Information Services
Division, U.S. Patent and Trademark
Office, P.O. Box 1450, Alexandria, VA
22313–1450. Federal e-Rulemaking
Portal: https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Requests for additional information
should be directed to the attention of
Janis Long, Attorney Advisor, Office of
the Commissioner for Trademarks,
United States Patent and Trademark
Office, P.O. Box 1450, Alexandria, VA
22313–1450; by telephone at 571–272–
9573; or by e-mail at
janis.long@uspto.gov.
SUPPLEMENTARY INFORMATION:
I. Abstract
The United States Patent and
Trademark Office (USPTO) administers
the Trademark Act, 15 U.S.C. 1051 et
seq., which provides for the Federal
registration of trademarks, service
marks, collective trademarks and service
marks, collective membership marks,
and certification marks. Individuals and
businesses that use, or intend to use
such marks in commerce may file an
application to register their marks with
the USPTO. Registered marks remain on
the register indefinitely so long as the
owner of the registration files the
necessary maintenance documents.
PO 00000
Frm 00016
Fmt 4703
Sfmt 4703
20257
Such individuals and businesses may
also submit various communications to
the USPTO regarding their pending
applications or registered trademarks,
including providing additional
information needed to process a
pending application, filing amendments
to the applications, or filing the papers
necessary to keep a trademark in force.
In the majority of circumstances,
individuals and businesses retain
attorneys to handle these matters. As
such, these parties may also submit
communications to the USPTO
regarding the appointment of attorneys
of record or domestic representatives to
represent applicants in the application
process, the revocation of an attorney ’s
appointment, and requests for
permission to withdraw from
representation. Applicants and
registrants may also submit change of
owner’s address forms requesting that
the USPTO amend the record of an
application or registration by entering a
new address for the applicant or
registrant.
The rules implementing the
Trademark Act are set forth in 37 CFR
Part 2. In addition to governing the
registration of trademarks, the Act and
rules also govern the appointments and
revocations of attorneys and domestic
representatives. The trademark rules
provide the specifics for filing requests
for permission to withdraw as the
attorney of record. The requirements for
changes of the owner’s address are not
governed by the trademark rules, but are
outlined in the USPTO’s procedures.
The information in this collection is
available to the public.
The information in this collection can
be submitted in paper format or
electronically through the Trademark
Electronic Application System (TEAS).
However, there are no official paper
forms for these items. Individuals and
businesses can submit their own paper
forms, following the USPTO’s rules and
guidelines to ensure that all of the
necessary information is provided. This
collection contains three electronic
forms.
II. Method of Collection
Electronically if applicants submit the
information using the TEAS forms. By
mail or hand delivery if applicants
choose to submit the information in
paper form.
III. Data
OMB Number: 0651–0056.
Form Number(s): PTO Forms 2196,
2197, and 2201.
Type of Review: Extension of a
currently approved collection.
E:\FR\FM\15APN1.SGM
15APN1
]]>Agencies
[Federal Register Volume 73, Number 73 (Tuesday, April 15, 2008)]
[Notices]
[Pages 20256-20257]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-8058]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Patent and Trademark Office
[Docket No. PTO-P-2008-0015]
Grant of Interim Extension of the Term of U.S. Patent No.
4,650,787; Sanvar[supreg]
AGENCY: United States Patent and Trademark Office, Department of
Commerce.
ACTION: Notice of Interim Patent Term Extension.
-----------------------------------------------------------------------
SUMMARY: The United States Patent and Trademark Office has issued an
order granting interim extension under 35 U.S.C. 156(d)(5) for a fourth
one-year interim extension of the term of U.S. Patent No. 4,650,787.
FOR FURTHER INFORMATION CONTACT: Mary C. Till by telephone at (571)
272-7755; by mail marked to her attention and addressed to the
Commissioner for Patents, Mail Stop Hatch-Waxman PTE, P.O. Box 1450,
Alexandria, VA 22313-1450; by fax marked to her attention at (571) 273-
7755, or by e-mail to Mary.Till@uspto.gov.
SUPPLEMENTARY INFORMATION: Section 156 of Title 35, United States Code,
generally provides that the term of a patent may be extended for a
period of
[[Page 20257]]
up to five years if the patent claims a product, or a method of making
or using a product, that has been subject to certain defined regulatory
review, and that the patent may be extended for interim periods of up
to a year if the regulatory review is anticipated to extend beyond the
expiration date of the patent.
On March 24, 2008, Debiovision Inc., the exclusive agent of
Debiopharm S.A. and Debio Recherche Pharmaceutique S.A., who is the
exclusive licensee of the Administrators of the Tulane Educational Fund
of New Orleans, Louisiana, the patent owner, timely filed an
application under 35 U.S.C. 156(d)(5) for a fourth interim extension of
the term of U.S. Patent No. 4,650,787. The patent claims the human drug
product Sanvar[supreg] (vapreotide acetate). The application indicates
that a New Drug Application for the human drug product Sanvar[supreg]
(vapreotide acetate) has been filed and is currently undergoing
regulatory review before the Food and Drug Administration for
permission to market or use the product commercially.
Review of the application indicates that except for permission to
market or use the product commercially, the subject patent would be
eligible for an extension of the patent term under 35 U.S.C. 156, and
that the patent should be extended for an additional one year as
required by 35 U.S.C. 156(d)(5)(B). Because it is apparent that the
regulatory review period will continue beyond the extended expiration
date of the patent (April 25, 2008), a fourth interim extension of the
patent term under 35 U.S.C. 156(d)(5) is appropriate.
A fourth interim extension under 35 U.S.C. 156(d)(5) of the term of
U.S. Patent No. 4,650,787 is granted for a period of one year from the
extended expiration date of the patent, i.e., until April 25, 2009.
Dated: April 9, 2008.
Jon W. Dudas,
Under Secretary of Commerce for Intellectual Property and Director of
the United States Patent and Trademark Office.
[FR Doc. E8-8058 Filed 4-14-08; 8:45 am]
BILLING CODE 3510-16-P
